Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)
The Oncologist, Volume 25, Issue 12, Page e1855-e1863, December 2020.
Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101)
The Oncologist, Volume 25, Issue 12, Page e1869-e1878, December 2020.
Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer
The Oncologist, Volume 25, Issue 12, Page e1879-e1885, December 2020.
Single‐Agent Versus Double‐Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial
The Oncologist, Volume 25, Issue 12, Page e1900-e1908, December 2020.
A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer
The Oncologist, Volume 25, Issue 12, Page e1893-e1899, December 2020.
A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild‐Type, Advanced Triple‐Negative Breast Cancer
The Oncologist, Volume 25, Issue 12, Page 1013-e1824, December 2020.
Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer
The Oncologist, Volume 25, Issue 12, Page e1864-e1868, December 2020.
A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with…
The Oncologist, Volume 25, Issue 12, Page e1846-1854, December 2020.
The Hospitalist Model and Oncology: Oncologist Opinions About Inpatient Cancer Care Delivery
The Oncologist, Volume 25, Issue 12, Page e2006-e2009, December 2020.
A Timely Oral Option: Single‐Agent Vinorelbine in Desmoid Tumors
The Oncologist, Volume 25, Issue 12, Page e2013-e2016, December 2020.
Pregnancy in Women with Metastatic Sarcomas
The Oncologist, Volume 25, Issue 12, Page e2010-e2012, December 2020.
Reviewer Acknowledgment
The Oncologist, Volume 25, Issue 12, Page e2029-e2031, December 2020.
Reviewer Acknowledgment
The Oncologist, Volume 25, Issue 12, Page e2032-e2054, December 2020.
In Reply
The Oncologist, Volume 25, Issue 12, Page e2018-e2018, December 2020.
Regarding “The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors”
The Oncologist, Volume 25, Issue 12, Page e2017-e2017, December 2020.
Clinical Impact of Plasma and Tissue Next‐Generation Sequencing in Advanced Non‐Small Cell Lung Cancer: A Real‐World Experience
The Oncologist, Volume 25, Issue 12, Page e1996-e2005, December 2020.
AR‐V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost‐Saving Analysis
The Oncologist, Volume 25, Issue 12, Page e1990-e1995, December 2020.
Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices
The Oncologist, Volume 25, Issue 12, Page 1032-1038, December 2020.
Adjuvant Treatment with 5‐Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer
The Oncologist, Volume 25, Issue 12, Page e1956-e1967, December 2020.
Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
The Oncologist, Volume 25, Issue 12, Page e1968-e1979, December 2020.
Table of Contents for The Oncologist. List of articles from both the latest and EarlyView issues.
Subscribe to Early View from The Oncologist feed